Online Inquiry 
1-303-522-8502 
:[email protected]
Online Inquiry 1-303-522-8502 :[email protected]
| Product Name | K562 ADM/Adriamycin Resistant Cell Line |
| Cat.No | RG-503 |
| Size | 1*10^6 cells/vial |
| Description | K562/ADM Resistant Cell Line was developed by stepwise increased concentrations of Adriamycin. Cells were continuously maintained in Adriamycin, with treatments beginning at the initial IC50 of the respective parent cell lines. |
| Tissue | Hemo-lymphocytic |
| Species | Human |
| Disease | Leukemia |
| Parental Cell Line | K562 |
| Biosafety Level | BSL 1. Runtogen determines the biosafety level of a material based on our risk assessment as guided by the current edition of Biosafety in Microbiological and Biomedical Laboratories (BMBL), U.S. Department of Health and Human Services. |
| Resistance | Adriamycin |
| Morphology | Lymphoblast-like, Suspension |
| Culture Method | RPMI-1640+10%FBS+10ng/ml adriamycin |
| Shipping | Cryopreserved cells are shipped with dry ice |
| Storage | Upon arrival, Check all containers for leakage or breakage. Remove the frozen cells from the dry ice packaging and immediately place the cells at a temperature below -130°C, preferably in liquid nitrogen vapor, until ready for use. |
| Warranty | Our Cell Line is warranted for 30 days from the date of shipment, provided that the customer has stored and handled the product according to the information included on the product datasheet, website, and COA. |
| Disclaimers | This cell line is intended for laboratory research use only. It is not intended for any human or animal therapeutic use, any animal or human consumption, or any diagnostic use. Any proposed commercial use is prohibited without a license from Runtogen. |
Inquire the K562 ADM/Adriamycin Resistant Cell Line by filling out the form below. We’ll get back to you within 24 hours with a quote.
Inquire the K562 ADM/Adriamycin Resistant Cell Line by filling out the form below. We’ll get back to you within 24 hours with a quote.
